Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05261295
Other study ID # E1-21-2260
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 2022
Est. completion date July 2022

Study information

Verified date February 2022
Source Ankara City Hospital Bilkent
Contact Ahmet Demirörs, MD
Phone +905548997181
Email drahmetdemirors@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The main purpose of the study is to compare the effectiveness of PEEP application in terms of perioperative oxygenation level in the use of classical LMA and i-gel, which is often preferred. The secondary aim is to compare parameters such as gastric insufflation and the rate of postoperative pulmonary complication development in the case of PEEP with two supraglottic airway devices.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 128
Est. completion date July 2022
Est. primary completion date June 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - ASA I-III - Patients who will undergo transurethral resection of the bladder and prostate taken in the lithotomy position, ureter and kidney stone operations with ureteroscopy Exclusion Criteria: - Heart failure (ejection fraction < 40%), - unstable hemodynamic conditions - Having neck or upper respiratory tract pathology, - have an increased risk of aspiration (gastroesophageal reflux disease, full stomach, acidity), - obesity (body mass index=30 kg m-2) - Patients with poor tooth structure will also be excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
PEEP
PEEP of 7 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.
ZEEP
PEEP of 0 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Outcome

Type Measure Description Time frame Safety issue
Primary LUS score preop Loss of ventilation will be evaluated by calculating the LUS score. Each region will be scored according to the LUS model as follows: Presence of lung deviation with lines or less than two isolated B-lines is scored as 0; 1 point in the presence of more than one well-defined B line; presence of more than one combined B line, 2 points; and when a tissue pattern characterized by dynamic air bronchograms (lung consolidation) is presented, the score is 3. The worst ultrasound pattern observed in each region will be recorded and used to calculate the sum of the scores. Baseline
Primary LUS score postoperative Loss of ventilation will be evaluated by calculating the LUS score. Each region will be scored according to the LUS model as follows: Presence of lung deviation with lines or less than two isolated B-lines is scored as 0; 1 point in the presence of more than one well-defined B line; presence of more than one combined B line, 2 points; and when a tissue pattern characterized by dynamic air bronchograms (lung consolidation) is presented, the score is 3. The worst ultrasound pattern observed in each region will be recorded and used to calculate the sum of the scores. postoperative 1.hour
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04057625 - Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated Pneumonia N/A
Terminated NCT02556853 - Ultrasound for Double Lumen Endotracheal Tube N/A
Active, not recruiting NCT03546699 - Hospital-wide Incidence, Clinical Characteristics and Outcomes of ARDS
Recruiting NCT03619525 - Ultrasonographic Assessment of the Effect of CPB Acute Lung Injury N/A
Completed NCT05132036 - Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients N/A
Not yet recruiting NCT04618627 - Role of Lung Ultrasonography in Prediction of the Seveity and the Need for Surfactant Administration in Neonates With Respiratory Distress Syndrome
Completed NCT04474236 - Lung Ultrasound for COVID-19 Initial Triage and Monitoring
Active, not recruiting NCT05035459 - B-lines-guided Heart Failure Management in Heart Failure Patients
Not yet recruiting NCT05272982 - Thoracic Fluid Content by Electrical Cardiometry Versus Lung Ultrasound in Mechanically Ventilated Patients
Not yet recruiting NCT06235645 - dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Recruiting NCT06430229 - Atelectasis Frequency in Different Ventilation Modes N/A
Completed NCT04719234 - Lung Ultrasonography in COVID-19 Pneumonia N/A
Not yet recruiting NCT06443528 - Comparison of Lung Ultrasound Scores With Clinical Models for Predicting Bronchopulmonary Dysplasia:A Multi-center Prospective Cohort Study
Recruiting NCT05481723 - Lung Ultrasound-guided Hemodynamic Optimization N/A
Recruiting NCT05024942 - LUS in Aortic Stenosis Patients Undergoing TAVR
Completed NCT05706441 - Lung and Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in COVID-19 Patients
Recruiting NCT05175313 - Transthoracic Ultrasonography Findings and Their Relation to Spirometric Indices in Patients With Obstructive and Restrictive Respiratory Diseases
Completed NCT04805684 - Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia N/A
Recruiting NCT06157138 - Observation of B-lines in Pulmonary Echography, During Open Abdominal Surgery
Completed NCT05171608 - Preoperative Ultrasound-based Protocol for Optimization of Fluid Therapy to Prevent Early Intraoperative Hypotension N/A